Importance of sleep restoration in co-morbid disease: Effect of anticonvulsants

Neurology

Volumn 54, Issue 5 SUPPL. 1, 2000, Pages

  Ehrenberg, Bruce ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; GABAPENTIN; VALPROIC ACID;

COMORBIDITY; CONFERENCE PAPER; DISEASE EXACERBATION; DRUG EFFECT; HUMAN; PRIORITY JOURNAL; REM SLEEP; RESTLESS LEGS SYNDROME; SEIZURE; SLEEP; SLEEP APNEA SYNDROME; SLEEP DEPRIVATION; SOMNOLENCE;

ANTICONVULSANTS; COMORBIDITY; EPILEPSY; HUMANS; SLEEP; SLEEP DISORDERS;

EID: 0034646338     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (60)

1. Kryger MH, Roth T, Dement WC, eds. Principles and practice of sleep medicine. 2nd ed. Philadelphia: WB Saunders, 1994.
2. Diagnostic Classification Steering Committee, Thorpy MJ, Chairman. International classification of sleep disorders: diagnostic coding manual. Rochester, MN: American Sleep Disorders Association, 1990.
3. Ohayon MM, Guilleminault C. Epidemiology of sleep disorders. In: Chokroverty S, ed. Sleep disorders medicine. 2nd ed. Boston: Butterworth-Heinemann, 1999:303-308.
4. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-1235.
5. Montplaisir J, Lavigne G. Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep 1994;17:739-743.
6. Roehrs T, Zorick F, Sickelsteel R, et al. Excessive daytime sleepiness associated with insufficient sleep. Sleep 1983;6: 319-325.
7. Mitler MM, Miller JC, Lipsitz JJ, Walsh JK, Wylie CD. The sleep of long haul truck drivers. N Engl J Med 1997;337:755-761.
8. Gastaut H, Tassinari CA, Duron B. Étude polygraphique des manifestations épisodiques (hypniques et respiratoires) diurnes et nocturnes, du syndrome de Pickwick. Rev Neurol 1965;112:568-579.
9. Lugaresi E, Coccagna G, Gambi D, Berti-Ceroni E, Poppi M. À propos quelques manifestations nocturnes myocloniques. (Nocturnal myoclonus de Symonds). Rev Neurol 1966;115: 547-555.
10. Lugaresi E, Tassinari CA, Coccagna G, Ambrosetto C. Particularités cliniques et polygraphiques du syndrome d'impatience des membres inférieurs. Rev Neurol 1965;113:545-555.
11. Bergmann BM, Gilliland MA, Feng P-F, et al. Are physiologic effects of sleep deprivation in the rat mediated by bacterial invasion? Sleep 1996;19:554-562.
12. Bergmann BM, Gilliland MA, Balzano S, Refetoff S, Rechtschaffen A. Sleep deprivation in the rat: XIX. Effects of thyroxine administration. Sleep 1995;18:317-324.
13. Everson CA, Gilliland MA, Kushida CA, et al. Sleep deprivation in the rat: IX. Recovery. Sleep 1989;12:60-67.
14. Katz SE, Landis C. Psychologic and physiologic phenomena during a prolonged vigil. Arch Neurol Psychiatry 1935;34: 307-316.
15. Berger RJ, Oswald I. Effects of sleep deprivation on behavior. Subsequent sleep and dreaming. J Ment Sci 1962;108:457-465.
16. Issa FG, Sullivan CE. The immediate effects of nasal continuous positive airway pressure treatment on sleep pattern in patients with obstructive sleep apnea syndrome. Electroencephalogr Clin Neurophysiol 1986;83:10-17.
17. Wittig R, Zorick F, Conway W, et al. Normalization of the MSLT after six weeks of CPAP for sleep apnea syndrome [abstract]. Sleep Res 1986;15:185.
18. Partinen M, Jamieson A, Guilleminault C. Long term outcome for obstructive sleep apnea syndrome patients: mortality. Chest 1988;94:1200-1204.
19. Fletcher EC. The relationship between systemic hypertension and obstructive sleep apnea: facts and theory. Am J Med 1995;98:118-128.
20. Koskenvuo M, Kaprio J, Partinen M, et al. Snoring as a risk factor for hypertension and angina pectoris. Lancet 1985;1: 893-896.
21. Koskenvuo M, Kaprio J, Telakivi T, et al. Snoring as a risk factor for ischaemic heart disease and stroke in men. BMJ 1987;294:16-19.
22. Palomaki H, Partinen M, Erkinjuntti T. Snoring, sleep apnea syndrome and stroke. Neurology 1992;42(suppl 6):75-82.
23. Neau JP, Meurice JC, Paquereau J, et al. Habitual snoring as a risk factor for stroke. Acta Neurol Scand 1995;92:63-68.
24. Eisensehr I, Ehrenberg BL, Noachtar S, et al. Platelet activation, epinephrine, and blood pressure in obstructive sleep apnea syndrome. Neurology 1998;51:188-195.
25. Bennett DR. Sleep deprivation and major motor convulsions. Neurology 1963;13:953-958.
26. Scollo-Lavizzari G, Scollo-Lavizzari GR. Sleep, sleep deprivation, photosensitivity, and epilepsy. Eur Neurol 1974;11:1-21.
27. Shouse MN. Sleep deprivation increases thalamocortical excitability in the somatomotor pathway, especially during seizure-prone sleep or awakening states in feline seizure models. Exp Neurol 1988;99:664-677.
28. Pratt KL, Mattson RH, Weikers NJ, et al. EEG activation of epileptics after sleep deprivation: a prospective study of 114 cases. Electroencephalogr Clin Neurophysiol 1968;24:11-15.
29. Fountain NB, Kim JS, Lee SI. Sleep deprivation activates epileptiform discharges independent of the activating effects of sleep. J Clin Neurophysiol 1998;15:69-75.
30. Gunderson CH, Dunne PB, Feyer TL. Sleep deprivation seizures. Neurology 1973;23:678-686.
31. Wyler AR, Weymuller EA. Epilepsy complicated by sleep apnea. Ann Neurol 1981;9:403-404.
32. Devinsky O, Ehrenberg B, Barthlen GM, Abramson HS, Luciano D. Epilepsy and sleep apnea syndrome. Neurology 1994; 44:2060-2064.
33. White DP, Zwillich CW, Pickett CK, et al. Central sleep apnea: improvement with acetazolamide therapy. Arch Intern Med 1982;142:1816-1819.
34. Zorick F, Roth T, Salis P, Kramer M, Lutz T. Insomnia and daytime excessive sleepiness as presenting symptoms in nocturnal myoclonus [abstract]. Sleep Res 1978;7:256.
35. Bixler E, Soldatos R, Scarone S, Martin E, Kales A, Charney D. Similarities of nocturnal myoclonic activity in insomniac patients and normal subjects [abstract]. Sleep Res 1978;7:213.
36. Mendelson WB. Are periodic leg movements associated with clinical sleep disturbance? Sleep 1996;19:219-223.
37. Wetter TC, Pollmacher T. Restless legs and periodic leg movements in sleep syndromes. J Neurol 1997;4(suppl 1):S37-45.
38. Ehrenberg BL. Valproate for periodic leg movements of sleep [abstract]. Electroencephalogr Clin Neurophysiol 1991;71:65P.
39. Paiva T, Farinha A, Martins A, Batista A, Guilleminault C. Chronic headaches and sleep disorders. Arch Intern Med 1997;157:1701-1705.
40. Kudrow L, McGinty DJ, Phillips ER, Stevenson M. Sleep apnea in cluster headache. Cephalalgia 1984;4:33-38.
41. Blau JN. Sleep deprivation headache. Cephalalgia 1990;10: 157-160.
42. Dexter JD. Headache as a presenting complaint of sleep-apnea syndrome [abstract]. Headache 1984;24:171.
43. Kales A, Bixler EO, Cadieux RJ, et al. Sleep apnoea in a hypertensive population. Lancet 1984;2:1005-1008.
44. Carlson JT, Hedner JA, Ejnell H, Peterson LE. High prevalence of hypertension in sleep apnea patients independent of obesity. Am J Respir Crit Care Med 1994;150:72-77.
45. Picchietti DL, England SJ, Walters AS, Willis K, Verrico T. Periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder. J Child Neurol 1998;13:588-594.
46. Hicks RA, Moore JD, Findley P, et al. REM sleep deprivation and pain thresholds in rats. Percept Motor Skills 1978;47: 848-850.
47. Older SA, Battafarano DF, Danning CL, et al. The effects of delta wave sleep interruption on pain thresholds and fibromyalgia-like symptoms in healthy subjects: correlations with insulin-like growth factor I. J Rheumatol 1998;25:1180-1186.
48. Max MB, Culnane M, Schager SC, et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 1987;37:589-596.
49. Jensen R, Brinck T, Olesen J. Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study. Neurology 1994;44:647-651.
50. Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. JAMA 1998;280:1831-1836.
51. Ehrenberg BL, Eisensehr I, Corbett KE, Crowley PF, Walters AS. Valproate for sleep consolidation in periodic limb movement disorder. J Clin Psychopharmacol, in press.
52. Placidi F, Diomedi M, Scalise A, Silvestri G, Marciani MG, Gigli GL. Effect of long-term treatment with gabapentin on nocturnal sleep in epilepsy [abstract]. Epilepsia 1997;38(suppl 8):179.
53. Nishino S, Mignot E, Dement WC. Sedative hypnotics. In: Schatzberg AF, Nemeroff CB, eds. Textbook of psychopharmacology. Washington, DC: American Psychiatric Press, 1995: 415-416.
54. Peled R, Lavie P. Double blind evaluation of clonazepam on periodic leg movements in sleep. J Neurol Neurosurg Psychiatry 1987;50:1679-1681.
55. Boxer CM, Heryberg JL, Scott DF. Has sodium valproate hypnotic effects? Epilepsia 1976;17:367-370.
56. Pies R, Adler D, Ehrenberg BL. Sleep disorder associated with "atypical depression": response to valproate. J Clin Psychopharmacol 1989;9:352-357.
57. Mellick GA, Mellick LB. Management of restless legs syndrome with gabapentin (Neurontin). Sleep 1996;19:224-226.
58. Adler CH. Treatment of restless legs syndrome with gabapentin. Clin Neuropharmacol 1997;20:148-151.
59. Ehrenberg BL, Muller-Schwarze A, Frankel F. Open-label trial of gabapentin for periodic limb movements disorder of sleep. Neurology 1997;4:A278-279.
60. Ehrenberg BL, Wagner AK, Corbett K, William H. Double-blind trial of gabapentin for periodic limb movement disorder of sleep: preliminary results [abstract]. Neurology 1998;50: A276.